The Experts below are selected from a list of 474 Experts worldwide ranked by ideXlab platform
Ela Durucu - One of the best experts on this subject based on the ideXlab platform.
-
comparison of the effectiveness of intralesional triamcinolone acetonide injection vs incision and curettage techniques in the treatment of Chalazion
Gaziantep Medical Journal, 2014Co-Authors: Ferhat Zorlu, Yusuf Kocluk, Emrah Mat, Ela DurucuAbstract:The aim of this study was to compare the effectiveness of intralesional triamcinolone acetonide injection with incision and curettage for the treatment of Chalazion. Forty-six patients who were treated with conservative measures for at least 1 month without any healing were included into the study. Twenty-seven of them were treated with intralesional triamcinolone acetonide injection and 19 of them with incision and curettage via conjunctival approach. Regression of Chalazion was observed in 24 (88%) of 27 patients who were injected intralesional triamcinolone acetonide, and 18 (95%) of 19 patients who were applied incision and curettage. No statistical difference was seen between the success rate of these two treatment options. There was not any complication in patients who were treated with incision and curettage but local depigmentation was seen in one patient (3.7%) who was treated with triamcinolone acetonide at the second month at follow-up. This depigmentation spontaneously disappeared at the 4th month. As a result in terms of success and complication ratios, effectiveness and reliability of these two methods were found similar in the treatment of Chalazion.
Adel H. Alsuhaibani - One of the best experts on this subject based on the ideXlab platform.
-
Clinical features differentiating intratarsal keratinous cyst from Chalazion
International Ophthalmology, 2020Co-Authors: Ahmad Alrubaian, Y H Al-faky, Hind M Alkatan, Adel H. AlsuhaibaniAbstract:Purpose To present the differentiating clinical findings between intratarsal keratinous cyst (IKC) and Chalazion. Method A retrospective review of medical records of all patients who presented between 2010 and 2018 at King Abdulaziz University Hospital with proven histopathological diagnosis of IKC was done. Complete ophthalmologic evaluation at presentation, surgical procedures performed, complications, histopathological findings, response to treatment and follow-up were recorded. Results Twelve patients were found to have IKC. All patients presented with an eyelid mass with no signs of local inflammation. All lesions were fixed to the tarsus with freely mobile overlying skin, which was found to be slightly pale compared to the surrounding skin in six patients. On palpation, IKC had well-defined boarders. Isolation with clear surgical plane for cyst excision was achieved in nine patients as they were superficially involving the tarsus. When IKC involved the deep part of the tarsus, bluish/ whitish nodules were seen upon eyelid eversion. Six patients were misdiagnosed and surgically treated as a Chalazion elsewhere prior to presentation to us with recurrence. Conclusion Differentiating IKC from Chalazion can be challenging. Careful clinical evaluation helps reaching the right diagnosis and providing the correct treatment, which involves complete excision of IKC to prevent recurrence.
-
clinical features differentiating intratarsal keratinous cyst from Chalazion
International Ophthalmology, 2020Co-Authors: Hind M Alkatan, Ahmad Alrubaian, Yasser H Alfaky, Adel H. AlsuhaibaniAbstract:To present the differentiating clinical findings between intratarsal keratinous cyst (IKC) and Chalazion. A retrospective review of medical records of all patients who presented between 2010 and 2018 at King Abdulaziz University Hospital with proven histopathological diagnosis of IKC was done. Complete ophthalmologic evaluation at presentation, surgical procedures performed, complications, histopathological findings, response to treatment and follow-up were recorded. Twelve patients were found to have IKC. All patients presented with an eyelid mass with no signs of local inflammation. All lesions were fixed to the tarsus with freely mobile overlying skin, which was found to be slightly pale compared to the surrounding skin in six patients. On palpation, IKC had well-defined boarders. Isolation with clear surgical plane for cyst excision was achieved in nine patients as they were superficially involving the tarsus. When IKC involved the deep part of the tarsus, bluish/ whitish nodules were seen upon eyelid eversion. Six patients were misdiagnosed and surgically treated as a Chalazion elsewhere prior to presentation to us with recurrence. Differentiating IKC from Chalazion can be challenging. Careful clinical evaluation helps reaching the right diagnosis and providing the correct treatment, which involves complete excision of IKC to prevent recurrence.
-
Large anterior orbital cyst as a late complication of Chalazion surgical drainage.
Eye (London England), 2015Co-Authors: Adel H. Alsuhaibani, Y H Al-fakyAbstract:To present four patients who developed large cystic lesions attached to the tarsal plate at the site of previously drained Chalazion. Medical records for all patients who developed cystic lesion as a complication of Chalazion surgery were retrospectively reviewed for clinical and radiological findings, treatment provided, histopathological findings, and complications. Four patients (one male and three females) with a mean age of 22 years (range, 11–36 years) were enrolled in the study. A history of Chalazion surgery was present in all patients at the same site of the cyst attachment to the tarsal plate. The mean interval between the presentation with the cystic lesion and the Chalazion surgery was 13 weeks (range, 6–24 weeks). All patients were treated with surgical excision of the cysts, along with local triamcinolone injection. Histopathological findings of the excised cysts were consistent with Chalazion. There was no evidence of recurrence or other complication observed during the follow-up visits (the minimum follow-up duration was 6 months). Anterior orbital cystic formation (prolapsed Chalazion) may occur as a late complication of Chalazion surgery. Surgical excision along with steroid injection was effective to manage this rare complication among our patients.
Ahmad Alrubaian - One of the best experts on this subject based on the ideXlab platform.
-
clinical features differentiating intratarsal keratinous cyst from Chalazion
International Ophthalmology, 2020Co-Authors: Hind M Alkatan, Ahmad Alrubaian, Yasser H Alfaky, Adel H. AlsuhaibaniAbstract:To present the differentiating clinical findings between intratarsal keratinous cyst (IKC) and Chalazion. A retrospective review of medical records of all patients who presented between 2010 and 2018 at King Abdulaziz University Hospital with proven histopathological diagnosis of IKC was done. Complete ophthalmologic evaluation at presentation, surgical procedures performed, complications, histopathological findings, response to treatment and follow-up were recorded. Twelve patients were found to have IKC. All patients presented with an eyelid mass with no signs of local inflammation. All lesions were fixed to the tarsus with freely mobile overlying skin, which was found to be slightly pale compared to the surrounding skin in six patients. On palpation, IKC had well-defined boarders. Isolation with clear surgical plane for cyst excision was achieved in nine patients as they were superficially involving the tarsus. When IKC involved the deep part of the tarsus, bluish/ whitish nodules were seen upon eyelid eversion. Six patients were misdiagnosed and surgically treated as a Chalazion elsewhere prior to presentation to us with recurrence. Differentiating IKC from Chalazion can be challenging. Careful clinical evaluation helps reaching the right diagnosis and providing the correct treatment, which involves complete excision of IKC to prevent recurrence.
-
Clinical features differentiating intratarsal keratinous cyst from Chalazion
International Ophthalmology, 2020Co-Authors: Ahmad Alrubaian, Y H Al-faky, Hind M Alkatan, Adel H. AlsuhaibaniAbstract:Purpose To present the differentiating clinical findings between intratarsal keratinous cyst (IKC) and Chalazion. Method A retrospective review of medical records of all patients who presented between 2010 and 2018 at King Abdulaziz University Hospital with proven histopathological diagnosis of IKC was done. Complete ophthalmologic evaluation at presentation, surgical procedures performed, complications, histopathological findings, response to treatment and follow-up were recorded. Results Twelve patients were found to have IKC. All patients presented with an eyelid mass with no signs of local inflammation. All lesions were fixed to the tarsus with freely mobile overlying skin, which was found to be slightly pale compared to the surrounding skin in six patients. On palpation, IKC had well-defined boarders. Isolation with clear surgical plane for cyst excision was achieved in nine patients as they were superficially involving the tarsus. When IKC involved the deep part of the tarsus, bluish/ whitish nodules were seen upon eyelid eversion. Six patients were misdiagnosed and surgically treated as a Chalazion elsewhere prior to presentation to us with recurrence. Conclusion Differentiating IKC from Chalazion can be challenging. Careful clinical evaluation helps reaching the right diagnosis and providing the correct treatment, which involves complete excision of IKC to prevent recurrence.
Ferhat Zorlu - One of the best experts on this subject based on the ideXlab platform.
-
comparison of the effectiveness of intralesional triamcinolone acetonide injection vs incision and curettage techniques in the treatment of Chalazion
Gaziantep Medical Journal, 2014Co-Authors: Ferhat Zorlu, Yusuf Kocluk, Emrah Mat, Ela DurucuAbstract:The aim of this study was to compare the effectiveness of intralesional triamcinolone acetonide injection with incision and curettage for the treatment of Chalazion. Forty-six patients who were treated with conservative measures for at least 1 month without any healing were included into the study. Twenty-seven of them were treated with intralesional triamcinolone acetonide injection and 19 of them with incision and curettage via conjunctival approach. Regression of Chalazion was observed in 24 (88%) of 27 patients who were injected intralesional triamcinolone acetonide, and 18 (95%) of 19 patients who were applied incision and curettage. No statistical difference was seen between the success rate of these two treatment options. There was not any complication in patients who were treated with incision and curettage but local depigmentation was seen in one patient (3.7%) who was treated with triamcinolone acetonide at the second month at follow-up. This depigmentation spontaneously disappeared at the 4th month. As a result in terms of success and complication ratios, effectiveness and reliability of these two methods were found similar in the treatment of Chalazion.
Can Y. F. Yuen - One of the best experts on this subject based on the ideXlab platform.
-
A comparison of intralesional triamcinolone acetonide injection for primary Chalazion in children and adults.
TheScientificWorldJournal, 2014Co-Authors: Jacky W. Y. Lee, Michelle Y. Y. Wong, Gordon S. K. Yau, Can Y. F. YuenAbstract:Purpose. To investigate outcome differences of intralesional triamcinolone acetonide (TA) injection for primary chalazia in children versus adults. Methods. A retrospective review of consecutive subjects with primary Chalazion who received intralesional TA injection was conducted. A single investigator injected 0.05–0.15 mL of TA (40 mg/mL) intralesionally. Patients were stratified into the pediatric (
-
a comparison of intralesional triamcinolone acetonide injection for primary Chalazion in children and adults
The Scientific World Journal, 2014Co-Authors: Jacky W. Y. Lee, Michelle Y. Y. Wong, Gordon S. K. Yau, Can Y. F. YuenAbstract:Purpose. To investigate outcome differences of intralesional triamcinolone acetonide (TA) injection for primary chalazia in children versus adults. Methods. A retrospective review of consecutive subjects with primary Chalazion who received intralesional TA injection was conducted. A single investigator injected 0.05–0.15 mL of TA (40 mg/mL) intralesionally. Patients were stratified into the pediatric (<18 years old) and adult (≥18 years old) group. In both groups, the correlation of resolution time with Chalazion size and TA dose was performed. Results. 17 children and 24 adults were enrolled, with a mean age of and years, respectively. Both groups had statistically similar baseline characteristics. There was no significant difference between the resolution time in the pediatric ( days) and adult ( days) group (). There were no significant complications from the TA injection. There was no significant correlation of resolution time to Chalazion size () nor TA dose () in both groups. Conclusion. TA for the treatment of primary Chalazion was equally effective in children and adults, without any significant complications, and the rate of clinical response did not appear to be dose-dependent.
-
Intralesional triamcinolone acetonide injection for the treatment of primary Chalazions.
International ophthalmology, 2014Co-Authors: Michelle Y. Y. Wong, Gordon S. K. Yau, Jacky W. Y. Lee, Can Y. F. YuenAbstract:The aim of this study was to investigate the safety and efficacy of intralesional triamcinolone acetonide (TA) injection in the treatment of primary Chalazions not responding to conservative treatment. Patient medical records were retrospectively reviewed for all consecutive patients that received intralesional TA injection by a single surgeon between January 2012 and March 2013 for the treatment of unresolved primary Chalazions despite 1 month of conservative treatment. The dose of TA injection ranged from 2 to 6 mg (40 mg/mL) depending on the size of the Chalazion. The main outcome measures included time to resolution, time to 50 % size reduction, and complications from the treatment. During the study period, 48 Chalazions from 38 patients were treated by intralesional TA injection. A 50 % reduction in size was achieved in 81.3 % of Chalazions in 4 weeks and 83 % achieved complete resolution in 6 weeks. The mean time to complete resolution was 15.7 ± 10.0 days. There were no complications noted from the injections; 14.6 % required subsequent incision and curettage and 2.1 % required a second TA injection for complete resolution. Intralesional TA injection is a safe, simple, and effective procedure for the management of primary Chalazions and may be considered as an alternative to incision and curettage in cases not responding to conservative treatment.